Catalyst Biosciences Inc.
13F holders, Q1 2025 (March 31)1holders
1new positions
1sold out
$7.73avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Catalyst Biosciences Inc. in their 13F filings, unchanged from Q4 2024. 1 opened new positions and 1 sold out. The largest holder was EverSource Wealth Advisors, LLC ($170).
- Company
- Catalyst Biosciences Inc.
- Filed as
- GYRE THERAPEUTICS INC COM (Q1 2025)
- CUSIP
- 14888D208
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $170 |
| Exits | 1 | $182 |
All 13F filers, Q4 2024 → Q1 2025: 22 shares bought and 15 shares sold, net +7 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| EverSource Wealth Advisors, LLC | 0.00% | New | 22 | $170 |
"% of holder's portfolio" is CATALYST BIOSCIENCES INC's weight in each manager's 13F, not the share of Catalyst Biosciences Inc. the manager owns.